INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 428m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
Public company

QCLSQ/C TECHNOLOGIES, INC.

CIK 0001321834

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score21
Connections7with evidence

QCLS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GM
Glass MitchellDirector, Chief Medical Officer
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 4, 2026
  • ← Insider ofevidence
    Voss Chelsea SierraDirector · Apr 15, 2026
  • ← Insider ofevidence
    Silverman JoshuaDirector, Executive Chairman · Apr 15, 2026
  • ← Insider ofevidence
    White Billy JoeDirector · Apr 15, 2026
9
FS
Friscia StephenDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A
—
50.0K sh
Apr 13, 2026
Apr 15, 2026
traded Apr 13, 2026
+2d
SEC FORM 4

Evidence

9
WJ
White Billy JoeDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
BB
Bernstein BruceDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
VS
Voss Chelsea SierraDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

21
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
162.2K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Friscia StephenDirector · Apr 15, 2026
  • ← Insider ofevidence
    Bernstein BruceDirector · Apr 15, 2026
  • ← Insider ofevidence
    Glass MitchellDirector, Chief Medical Officer · Apr 15, 2026